Found: 1
Select item for more details and to access through your institution.
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.
- Published in:
- Oncologist, 2018, v. 23, n. 8, p. 889, doi. 10.1634/theoncologist.2018-0149
- By:
- Publication type:
- Article